AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1654756
Drug: 20-gauge intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-gauge intravenous catheter
Trial: 8471832
Drug: Pindolol 5
RxNorm normalized name: pindolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 5 mg
Trial: 29316176
Drug: Prandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prandial insulin glulisine injection timing adjustment based on continuous glucose monitoring (arm B)
Trial: 29316176
Drug: Pre-breakfast insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-breakfast insulin glulisine injection (arm A)
Trial: 29316176
Drug: Prandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prandial insulin glulisine dosage (arm B)
Trial: 29316176
Drug: Prandial insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prandial insulin glulisine dosage (arm A)
Trial: 25296241
Drug: Intrapleural tPA/DNase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural tPA/DNase therapy
Trial: 10346769
Drug: Promethazine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine (25 mg for adults and 0.5/kg for children)
Trial: 28137739
Drug: Etoposide 50
RxNorm normalized name: etoposide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide 50 mg/m2 on days 1-5 and cisplatin 50 mg/m2 on days 1 and 8 every 4 weeks for two cycles (EP arm)
Trial: 28137739
Drug: Paclitaxel 45
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 45 mg/m2 and carboplatin (AUC 2) on day 1 weekly (PC arm)
Trial: 30517889
Drug: Active CPAP
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active CPAP treatment
Trial: 17406837
Drug: Arginine (Arg;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arginine (Arg; 20 g)
Trial: 18035195
Drug: Ibutilide 0.005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide 0.005 mg/kg
Trial: 8752805
Drug: Ibutilide 0.025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibutilide 0.025 mg/kg
Trial: 6419419
Drug: Valproic acid
RxNorm normalized name: Valproic Acid
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproic acid (Depakene capsules, Abbott)
Trial: 25246664
Drug: Inhaled mannitol
RxNorm normalized name: mannitol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled mannitol 400 mg twice a day for 52 weeks
Trial: 21796421
Drug: 17 alpha-hydroxyprogesterone
RxNorm normalized name: 17 alpha-hydroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17 alpha-hydroxyprogesterone caproate (17‐OHPC) 250 mg intramuscularly
Trial: 9414326
Drug: Daily contact
RxNorm normalized name: CONTACT LENS DAILY CLEANER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily contact with a nurse and home monitoring of uterine activity
Trial: 26320081
Drug: Integrated intensive
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated intensive smoking plus alcohol intervention using cognitive behavioral therapy (CBT)
Trial: 22818224
Drug: Intravenous omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous omeprazole 0.5mg/kg every 12 hours
Trial: 16540816
Drug: Family-focused cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-focused cognitive behavioral therapy (CBT; the Building Confidence Program)
Trial: 16540816
Drug: Child-focused cognitive
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Child-focused cognitive behavioral therapy (CBT) with minimal family involvement
Trial: 15978303
Drug: Azelastine nasal
RxNorm normalized name: azelastine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine nasal spray (2 sprays per nostril twice daily)
Trial: 9311405
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine (50 mg)
Trial: 9311405
Drug: Intraperitoneal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal morphine (50 mg)
Trial: 30340425
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of leucine immediately after a mixed meal (MEAL-LEU)
Trial: 30340425
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of leucine 180 min after a mixed meal (MEAL-LEU180)
Trial: 27541690
Drug: Dietary LCω3PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary LCω3PUFA intake of at least 500 mg/d
Trial: 27541690
Drug: Not meeting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not meeting the LCω3PUFA recommendation (<500 mg/d)
Trial: 17568402
Drug: Buprenorphine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine with ultra-low-dose naloxone
Trial: 12027854
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural analgesia with a bupivacaine/morphine infusion (EPI-group, n=6)
Trial: 12027854
Drug: Continuous i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous i.v. infusion of morphine (MO-group, n=8)
Trial: 24519200
Drug: Oxybutynin 10
RxNorm normalized name: oxyBUTYnin 10% transdermal gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 10 mg daily
Trial: 20947066
Drug: METH (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: METH (20 mg)
Trial: 9925239
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ASA and DP
Trial: 554446
Drug: Haloperidol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (10 to 60 mg daily)
Trial: 25618965
Drug: Control (routine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (routine therapy alone)
Trial: 23072088
Drug: Non-acupoints treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-acupoints treatment
Trial: 12515574
Drug: Basiliximab (20mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basiliximab (20mg intravenous bolus on day 0 and day 4)
Trial: 10713317
Drug: Warfarin dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin dosage scheme based on a transition factor of 2.3 times the phenprocoumon dose; no specific dosage or duration mentioned.
Trial: 1567347
Drug: Multicomponent psychological
RxNorm normalized name: meningococcus B, multicomponent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent psychological treatment (relaxation, thermal biofeedback, and cognitive therapy)
Trial: 2416566
Drug: Pirmenol, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirmenol, 200 mg twice daily
Trial: 29633507
Drug: GV1001 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GV1001 0.4 mg, 2‐week interval
Trial: 29633507
Drug: GV1001 0.56
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GV1001 0.56 mg, 2‐week interval
Trial: 29633507
Drug: GV1001 0.56
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GV1001 0.56 mg, 4‐week interval
Trial: 10228867
Drug: 5‐FU plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐FU plus continuous infusion of low‐dose CDDP (A‐2, B‐2)
Trial: 10228867
Drug: 5‐FU plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐FU plus bolus infusion of CDDP (A‐1, B‐1)
Trial: 1887821
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated estrogen daily plus variable-resistance weight training
Trial: 1887821
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated estrogen daily
Trial: 31601239
Drug: HemoSphere with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HemoSphere with HPI used to guide treatment
Trial: 22489072
Drug: 7-item predictive
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 7-item predictive score including age <1 year, epilepsy, congenital/genetic conditions, history of transplant, enteral tube, hemoglobin <10 g/dL, blood culture drawn in the preceding 72 hours
Trial: 15567879
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist + rFSH
Trial: 8901789
Drug: 300 g
RxNorm normalized name: Zantac 300 GELdose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 g Brussels sprouts/d for 3 weeks
Trial: 8901789
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg eugenol/d in capsule form
Trial: 1876744
Drug: Mepivacaine 1%
RxNorm normalized name: mepivacaine 1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine 1% 40 ml + phentanyl 100 micrograms
Trial: 1876744
Drug: Mepivacaine 1%
RxNorm normalized name: mepivacaine 1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine 1% 40 ml + subcutaneous phentanyl 100 micrograms
Trial: 1876744
Drug: Mepivacaine 1%
RxNorm normalized name: mepivacaine 1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepivacaine 1% 40 ml (control group)
Trial: 6283645
Drug: tiapride (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiapride (900 mg per day for three months)
Trial: 30081380
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg ketamine infusion
Trial: 27143213
Drug: Dabigatran 220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dabigatran 220 mg once daily (starting with 110 mg half-dose, 1-4 hours after surgery)
Trial: 27143213
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg once daily (starting the evening before surgery)
Trial: 26121789
Drug: Hypotonic electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypotonic electrolyte solution with 2.6% glucose (HT)
Trial: 12925471
Drug: Etomidate 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.2 mg kg(‐1)
Trial: 12925471
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg kg(‐1)
Trial: 12925471
Drug: Etomidate 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.4 mg kg(‐1)
Trial: 10683103
Drug: Creatine (Cr)
DrugBank: Creatine (DB00148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatine (Cr) supplementation (5 g of Cr plus 1 g of sucrose 4x per day)
Trial: 10683103
Drug: Placebo (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (6 g of sucrose placebo 4x per day)
Trial: 30357297
Drug: Myo-inositol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myo-inositol (40 mg/kg every 12 hours for up to 10 weeks)
Trial: 10512080
Drug: Amisulpride 50
RxNorm normalized name: amisulpride 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 50 mg/day
Trial: 10200742
Drug: Amisulpride 100
RxNorm normalized name: amisulpride 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride 100 mg/day
Trial: 8848950
Drug: Clomipramine (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (100-150 mg/day)
Trial: 8848950
Drug: Moclobemide (400-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (400-600 mg/day)
Trial: 2330930
Drug: Oral rhesus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rhesus rotavirus vaccine at a dose of 10(4) plaque‐forming units
Trial: 25652873
Drug: AS03-adjuvanted H5N1
RxNorm normalized name: AS03 Adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03-adjuvanted H5N1 influenza vaccine (1·9 μg or 3·75 μg hemagglutinin antigen)
Trial: 15572199
Drug: Tobramycine eye
RxNorm normalized name: Tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Tobramycine eye drops alone or in combination with cyclosporine A, diclofenac, or rimexolone
Trial: 2198822
Drug: Intravenous immunoglobulin-G
RxNorm normalized name: immunoglobulin G
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin-G (IVIG)
Trial: 26048185
Drug: Dapagliflozin/metformin XR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin/metformin XR FDC tablets (administered with a light-fat meal)
Trial: 23354187
Drug: Routine heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine heparin R‐AHD
Trial: 23354187
Drug: Half-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose heparin R‐AHD
Trial: 23354187
Drug: Routine heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine heparin DNHD (control)
Trial: 23354187
Drug: Routine heparin-mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine heparin-mixed AHD PR
Trial: 8932015
Drug: Air-fluidised bed
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air-fluidised bed therapy at 32 degrees C (Group B)
Trial: 1873204
Drug: Bath treatment
RxNorm normalized name: Aveeno Soothing Bath Treatment
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bath treatment (8-methoxypsoralen)
Trial: 6355795
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy (Tinidazole and Cephamandole)
Trial: 30326639
Drug: Reduced dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced dairy intake (−14.6 ± 3.0 g/day)
Trial: 30326639
Drug: Maintained dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintained dairy intake (−4.0 ± 2.0 g/day)
Trial: 30326639
Drug: Increased dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dairy intake (+13.8 ± 4.1 g/day)
Trial: 26764321
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g LNS (Lipid-Based Nutrient Supplement)
Trial: 26764321
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg iron + 400 μg folic acid (IFA)
Trial: 22555894
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone 1 mg/kg/d (tapered gradually)
Trial: 22555894
Drug: Intrapolyp injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapolyp injection of triamcinolone acetonide (0.3 mL, 40 mg/mL)
Trial: 22555894
Drug: Topical triamcinolone
RxNorm normalized name: triamcinolone Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical triamcinolone acetonide (55 µg, 2 times daily for 1 month)
Trial: 22555894
Drug: Intrapolyp injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapolyp injection vs Topical triamcinolone
Trial: 20473745
Drug: Shenmai Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenmai Injection (SMI) given to the observation group for 14 days along with basic treatment including polarized liquid therapy.
Trial: 20473745
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received basic treatment including polarized liquid therapy without SMI.
Trial: 15476904
Drug: Telmisartan 40
RxNorm normalized name: telmisartan 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 40 mg once daily for 12 months
Trial: 18712038
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg once daily for 12 months
Trial: 12874080
Drug: Short-course clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course clindamycin (3 doses)
Trial: 12874080
Drug: Long-course clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course clindamycin (15 doses)
Trial: 1524898
Drug: Breast-conserving therapy
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast-conserving therapy (BCT)
Trial: 8945129
Drug: Daily vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vaginal douche for one day (Group A)
Trial: 8945129
Drug: Daily vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily vaginal douche for four days (Group B)
Trial: 28315479
Drug: personalized pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: personalized pharmaceutical and general education
Trial: 19728887
Drug: 500 mcg
RxNorm normalized name: Nplate 500 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mcg darbepoetin alfa every three weeks (Q3W)
Trial: 19728887
Drug: 2.25 mcg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.25 mcg/kg darbepoetin alfa weekly (QW)
Trial: 15966757
Drug: Cocaine 20
RxNorm normalized name: cocaine 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine 20 mg
Trial: 15966757
Drug: Cocaine 40
RxNorm normalized name: cocaine 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine 40 mg
Trial: 22122605
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without treatment
Trial: 24946226
Drug: Topical sucralfate
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical sucralfate mouthwash
Trial: 24946226
Drug: Topical clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clindamycin mouthwash
Trial: 19582577
Drug: Assistant-administered abdominal
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assistant-administered abdominal pressure
Trial: 15921866
Drug: Felodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine (5 mg/d)
Trial: 9470315
Drug: Captopril 100
RxNorm normalized name: captopril 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 100 mg (Group 3)
Trial: 23558909
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy (GDT)
Trial: 24935686
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g of ethanol/kilogram bodyweight, taken orally immediately before lights off
Trial: 21529370
Drug: Depression Recognition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depression Recognition and Treatment package (DepReT-Stroke) in addition to treatment as usual (TAU)
Trial: 19195498
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg once a day
Trial: 19195498
Drug: atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 40 mg once a day
Trial: 7892024
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (EM) 4 mg administered via the L2-L3 intervertebral space
Trial: 7892024
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (EM) 4 mg administered pre-trauma
Trial: 3287226
Drug: Defibrotide at
RxNorm normalized name: defibrotide
DrugBank: Defibrotide (DB04932)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Defibrotide at a dose of 400 mg b.i.d. i.v. in 50 ml phleboclysis in 5 minutes (n = 108)
Trial: 3287226
Drug: Calcium heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium heparin at a dose of 5000 IU t.i.d. subcutaneously (n = 103)
Trial: 31898965
Drug: WBC count
RxNorm normalized name: oteseconazole
DrugBank: Oteseconazole (DB13055)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: WBC count at baseline (per 1 × 10^9/L increase)
Trial: 30501618
Drug: 1 dose
RxNorm normalized name: Ribose 3 GM/1 DOSE Oral Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 dose of intravenous dexamethasone and 1 dose of normal saline (Group B)
Trial: 23827107
Drug: Injection/oral itraconazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection/oral itraconazole
Trial: 15571210
Drug: Bumetanide 4
RxNorm normalized name: Bumetanide
DrugBank: Bumetanide (DB00887)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bumetanide 4 mg/day
Trial: 29475008
Drug: rosuvastatin 20
RxNorm normalized name: rosuvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 20 mg/day (R20)
Trial: 29475008
Drug: atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 10 mg/day combined with ezetimibe 10 mg/day (A10 + E10)
Trial: 27496680
Drug: Thalidomide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (200 mg daily)
Trial: 18454864
Drug: Intravenous antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotics for 8 days
Trial: 14551179
Drug: Ragaglitazar 4
RxNorm normalized name: Ragaglitazar
DrugBank: Ragaglitazar (DB06533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ragaglitazar 4 mg for 21 days in patients with type 2 diabetes
Trial: 14551179
Drug: Ragaglitazar (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ragaglitazar (various doses 0.5-16 mg) for healthy subjects
Trial: 8792760
Drug: antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antidepressant treatment (amitriptyline hydrochloride, fluoxetine hydrochloride, toloxatone)